Abiopharma

GOODRX HOLDINGS, INC. (GDRX)

Symbol	GDRX
Name	GOODRX HOLDINGS, INC.
Sector	TECHNOLOGY
Region	North America
Industry	EDP Services
Address	2701 OLYMPIC BOULEVARD, SANTA MONICA, California, 90404, United States
Telephone	+1 855 268-2822
Fax	—
Email	—
Website	https://www.goodrx.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001809519
Description	GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The companys primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee. Additional info from NASDAQ: GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The companys primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee.

2026-08-27 01:20

FRANCISCO PARTNERS IV, L.P. 🔴 sold 1.6M shares of GoodRx Holdings, Inc. (GDRX) at $3.51 ($5.5M) Transaction Date: Aug 24, 2026 | Filing ID: 369287

2026-08-26 22:24

New Form SCHEDULE 13D/A - GoodRx Holdings, Inc. Filed: 2026-08-26 AccNo: 0001193125-26-369290 Size: 20 KB

2026-08-22 01:38

FRANCISCO PARTNERS IV, L.P. 🟡 adjusted position in 5.9M shares (2 derivative) of GoodRx Holdings, Inc. (GDRX) at $3.53 ($4.2M) Transaction Date: Aug 19, 2026 | Filing ID: 361608

2026-08-19 18:21

📋 Francisco Partners GP IV, L.P. (10% Stockholder, Affiliate) plans to sell 2.8M shares of GoodRx Holdings, Inc. (at $3.72 each, total $10.3M) Filed: Aug 19, 2026 | ID: 356674

2026-08-17 22:28

Chan Thomas (TC) 🟡 adjusted position in 5.1K shares (4 derivative) of GoodRx Holdings, Inc. (GDRX) at $3.73 Transaction Date: Aug 15, 2026 | Filing ID: 000165

2026-08-17 22:27

Fengler Justin 🟡 adjusted position in 21.4K shares (4 derivative) of GoodRx Holdings, Inc. (GDRX) at $3.73 Transaction Date: Aug 15, 2026 | Filing ID: 000163

2026-08-12 21:25

Fengler Justin 🟢 acquired 190.2K shares (1 derivative) of GoodRx Holdings, Inc. (GDRX) Transaction Date: Aug 10, 2026 | Filing ID: 000159

2026-08-12 18:25

New Form 3 - GoodRx Holdings, Inc. Filed: 2026-08-12 AccNo: 0001809519-26-000157 Size: 375 KB

2026-08-05 20:05

GoodRx Reports Second Quarter 2026 Results

2026-07-16 20:26

McGinnis Christopher A 🟡 adjusted position in 16.3K shares (1 derivative) of GoodRx Holdings, Inc. (GDRX) at $3.01 Transaction Date: Jul 15, 2026 | Filing ID: 000138